Article in Infection and immunity, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Leonardo Moura MidonDepartment of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.ORCID 0000-0003-4231-2830
Amaro Nunes Duarte NetoDepartment of Pathology, Faculty of Medicine, University of São Paulo, São Paulo, Brazil.
Ana Maria Gonçalves da SilvaTropical Medicine Institute, Faculty of Medicine, University of São Paulo, São Paulo, Brazil.
Marcos Bryan HeinemannBacterial Zoonosis Laboratory, Medicine Veterinary School, University of São Paulo, São Paulo, Brazil.
Suman KunduDepartment of Microbiology, Immunology and Biochemistry, University of Tennessee Health Science Center, Memphis, Tennessee, USA.ORCID 0000-0002-8591-1166
Maria Gomes-SoleckiDepartment of Microbiology, Immunology and Biochemistry, University of Tennessee Health Science Center, Memphis, Tennessee, USA.ORCID 0000-0002-3715-4543
Lourdes IsaacDepartment of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.ORCID 0000-0002-7746-8942
Funding
Field trial and modeling of transmission blocking vaccine to prevent Lyme diseaseR01AI139267 · NIAID · UNIVERSITY OF IOWA · PI BROWN, GRANT D, GOMES-SOLECKI, MARIA · 2019 to 2023
$3.6M
Intranasal Vaccine Against Lyme DiseaseR44AI167605 · NIAID · IMMUNO TECHNOLOGIES, INC. · PI GOMES-SOLECKI, MARIA · 2022 to 2024
$3.0M
ImmunoPET Probes for the Imaging of Lyme DiseaseR01AI175417 · NIAID · HUNTER COLLEGE · PI Maria Gomes-Solecki, WEIGANG QIU · 2023 to 2026
$2.2M
Conselho Nacional de Desenvolvimento Científico e Tecnológico 312654/2021-9Fundação de Amparo à Pesquisa do Estado de São Paulo 2017/12924-3Fundação de Amparo à Pesquisa do Estado de São Paulo 2018/26574-7Fundação de Amparo à Pesquisa do Estado de São Paulo 2022/05793-8NIAID NIH HHS R01 AI139267NIAID NIH HHS R01 AI175417NIAID NIH HHS R44 AI167605NIH HHS R01AI139267NIH HHS R44AI167605
6 · The paper itself
Abstract
Leptospirosis is a neglected disease caused by pathogenic
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Complement C3 deficiency enhances renal leptospiral load and inflammation while impairing T cell differentiation during chronic · full record | OpenQuestion